Clinical Trial Update: Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating temsirolimus in advanced renal cell carcinoma has completed with results on safety, efficacy, and pharmacokinetics posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Pfizer | Conditions: Advanced Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-07-09